TY  - JOUR

T1  - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL ASSESSING THE TOLERABILITY AND EFFICACY OF GLUTATHIONE AS AN ADJUVANT TO ESCALATING DOSES OF CISPLATIN IN THE TREATMENT OF ADVANCED OVARIAN-CANCER

JO  - EUR J CANCER

PY  - 1995/09/01

AU  - PARNIS FX

AU  - COLEMAN RE

AU  - HARPER PG

AU  - PICKERING D

AU  - TOPHAM C

AU  - WHITTINGTON JR

AU  - TEDESCHI M

ED  - 

VL  - 31A

IS  - 10

SP  - 1721

EP  - 1721

Y2  - 2025/10/10

ER  -